Section for Cellular Therapy

Publications published since 1984 from OUS - Section for Cellular Therapy

132 publications found

Publications 2020

  1. Bai B, Myklebust JH, Wälchli S (2020)
    Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology
    Methods Mol Biol, 2115, 445-454
    DOI 10.1007/978-1-0716-0290-4_25, PubMed 32006416
  2. Benard E, Casey NP, Marit Inderberg E, Wälchli S (2020)
    A catalogue of Ovarian Cancer targets for CAR therapy
    Scand J Immunol, e12917 (in press)
    DOI 10.1111/sji.12917, PubMed 32557659
  3. Dillard P, Lie M, Baken E, Lobert VH, Benard E, Köksal H, Inderberg EM, Wälchli S (2020)
    Colorectal cysts as a validating tool for CAR therapy
    BMC Biotechnol, 20 (1), 30
    DOI 10.1186/s12896-020-00623-0, PubMed 32487146
  4. Inderberg EM, Wälchli S (2020)
    Long-term surviving cancer patients as a source of therapeutic TCR
    Cancer Immunol Immunother, 69 (5), 859-865
    DOI 10.1007/s00262-019-02468-9, PubMed 31915853
  5. Inderberg EM, Wälchli S (2020)
    Sympathetic improvement of cancer vaccine efficacy
    Hum Vaccin Immunother
    DOI 10.1080/21645515.2019.1703456, PubMed 31977269
  6. Kierulf-Vieira KS, Sandberg CJ, Waaler J, Lund K, Skaga E, Saberniak BM, Panagopoulos I, Brandal P, Krauss S, Langmoen IA, Vik-Mo EO (2020)
    A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
    Cancers (Basel), 12 (6)
    DOI 10.3390/cancers12061630, PubMed 32575464
  7. Lichtenegger FS, Schnorfeil FM, Rothe M, Deiser K, Altmann T, Bücklein VL, Köhnke T, Augsberger C, Konstandin NP, Spiekermann K, Moosmann A, Boehm S, Boxberg M, Heemskerk MH, Goerlich D, Wittmann G, Wagner B, Hiddemann W, Schendel DJ, Kvalheim G, Bigalke I, Subklewe M (2020)
    Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial
    Clin Transl Immunology, 9 (3), e1117
    DOI 10.1002/cti2.1117, PubMed 32153780
  8. Mensali N, Myhre MR, Dillard P, Pollmann S, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2020)
    Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
    Cancer Immunol Immunother, 69 (1), 159-161
    DOI 10.1007/s00262-019-02409-6, PubMed 31776597
  9. Weum Abrahamsen I, Grønvold BC, Inderberg EM, Mensali N, Mattsson J, Gedde-Dahl T (2020)
    Posttransplantation Lymphoproliferative Disease Treated by Retransplantation
    Case Reports Immunol, 2020, 9403123
    DOI 10.1155/2020/9403123, PubMed 32158568
  10. Winge-Main AK, Wälchli S, Marit Inderberg E (2020)
    T-cell receptor therapy (TCR) against melanoma -immunotherapy for the future?
    Scand J Immunol, e12927 (in press)
    DOI 10.1111/sji.12927, PubMed 32640053
  11. Wälchli S, Sioud M (2020)
    Next Generation of Adoptive T Cell Therapy Using CRISPR/Cas9 Technology: Universal or Boosted?
    Methods Mol Biol, 2115, 407-417
    DOI 10.1007/978-1-0716-0290-4_22, PubMed 32006413

Publications 2019

  1. Andersson Y, Inderberg EM, Kvalheim G, Herud TM, Engebraaten O, Flatmark K, Dueland S, Fodstad Ø (2019)
    Immune stimulatory effect of anti-EpCAM immunotoxin - improved overall survival of metastatic colorectal cancer patients
    Acta Oncol, 59 (4), 404-409
    DOI 10.1080/0284186X.2019.1704864, PubMed 31876430
  2. Camilio KA, Wang MY, Mauseth B, Waagene S, Kvalheim G, Rekdal Ø, Sveinbjørnsson B, Mælandsmo GM (2019)
    Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model
    Breast Cancer Res, 21 (1), 9
    DOI 10.1186/s13058-018-1092-x, PubMed 30670061
  3. Josefsson SE, Beiske K, Blaker YN, Førsund MS, Holte H, Østenstad B, Kimby E, Köksal H, Wälchli S, Bai B, Smeland EB, Levy R, Kolstad A, Huse K, Myklebust JH (2019)
    TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma
    Cancer Immunol Res, 7 (3), 355-362
    DOI 10.1158/2326-6066.CIR-18-0351, PubMed 30659053
  4. Kyte JA, Fåne A, Pule M, Gaudernack G (2019)
    Transient redirection of T cells for adoptive cell therapy with telomerase-specific T helper cell receptors isolated from long term survivors after cancer vaccination
    Oncoimmunology, 8 (4), e1565236
    DOI 10.1080/2162402X.2019.1565236, PubMed 30906659
  5. Köksal H, Dillard P, Josefsson SE, Maggadottir SM, Pollmann S, Fåne A, Blaker YN, Beiske K, Huse K, Kolstad A, Holte H, Kvalheim G, Smeland EB, Myklebust JH, Inderberg EM, Wälchli S (2019)
    Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma
    Blood Adv, 3 (8), 1230-1243
    DOI 10.1182/bloodadvances.2018029678, PubMed 30979721
  6. Köksal H, Müller E, Inderberg EM, Bruland Ø, Wälchli S (2019)
    Treating osteosarcoma with CAR T cells
    Scand J Immunol, 89 (3), e12741
    DOI 10.1111/sji.12741, PubMed 30549299
  7. Mensali N, Dillard P, Hebeisen M, Lorenz S, Theodossiou T, Myhre MR, Fåne A, Gaudernack G, Kvalheim G, Myklebust JH, Inderberg EM, Wälchli S (2019)
    NK cells specifically TCR-dressed to kill cancer cells
    EBioMedicine, 40, 106-117
    DOI 10.1016/j.ebiom.2019.01.031, PubMed 30665853
  8. Mensali N, Grenov A, Pati NB, Dillard P, Myhre MR, Gaudernack G, Kvalheim G, Inderberg EM, Bakke O, Wälchli S (2019)
    Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity
    Oncoimmunology, 8 (3), 1558663
    DOI 10.1080/2162402X.2018.1558663, PubMed 30723591
  9. Mensali N, Myhre MR, Dillard P, Pollmann S, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2019)
    Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
    Cancer Immunol Immunother, 68 (8), 1235-1243
    DOI 10.1007/s00262-019-02356-2, PubMed 31214732
  10. Theodossiou TA, Ali M, Grigalavicius M, Grallert B, Dillard P, Schink KO, Olsen CE, Wälchli S, Inderberg EM, Kubin A, Peng Q, Berg K (2019)
    Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT-tamoxifen hybrid therapy
    NPJ Breast Cancer, 5, 13
    DOI 10.1038/s41523-019-0108-8, PubMed 30993194

Publications 2018

  1. Dillard P, Köksal H, Inderberg EM, Wälchli S (2018)
    A Spheroid Killing Assay by CAR T Cells
    J Vis Exp (142)
    DOI 10.3791/58785, PubMed 30596389
  2. Lampen MH, Uchtenhagen H, Blom K, Varnaitė R, Pakalniene J, Dailidyte L, Wälchli S, Lindquist L, Mickiene A, Michaëlsson J, Schumacher TN, Ljunggren HG, Sandberg JK, Achour A, Gredmark-Russ S (2018)
    Breadth and Dynamics of HLA-A2- and HLA-B7-Restricted CD8+ T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus Infection
    Immunohorizons, 2 (6), 172-184
    DOI 10.4049/immunohorizons.1800029, PubMed 31022685
  3. Våtsveen TK, Myhre MR, Steen CB, Wälchli S, Lingjærde OC, Bai B, Dillard P, Theodossiou TA, Holien T, Sundan A, Inderberg EM, Smeland EB, Myklebust JH, Oksvold MP (2018)
    Artesunate shows potent anti-tumor activity in B-cell lymphoma
    J Hematol Oncol, 11 (1), 23
    DOI 10.1186/s13045-018-0561-0, PubMed 29458389

Publications 2017

  1. Bollum LK, Huse K, Oksvold MP, Bai B, Hilden VI, Forfang L, Yoon SO, Wälchli S, Smeland EB, Myklebust JH (2017)
    BMP-7 induces apoptosis in human germinal center B cells and is influenced by TGF-β receptor type I ALK5
    PLoS One, 12 (5), e0177188
    DOI 10.1371/journal.pone.0177188, PubMed 28489883
  2. Eide N, Faye RS, Høifødt HK, Sandvik L, Qvale GA, Faber R, Jebsen P, Kvalheim G, Fodstad Ø (2017)
    The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy
    Pathol Oncol Res, 25 (1), 255-262
    DOI 10.1007/s12253-017-0355-7, PubMed 29098521
  3. Giustacchini A, Thongjuea S, Barkas N, Woll PS, Povinelli BJ, Booth CAG, Sopp P, Norfo R, Rodriguez-Meira A, Ashley N, Jamieson L, Vyas P, Anderson K, Segerstolpe Å, Qian H, Olsson-Strömberg U, Mustjoki S, Sandberg R, Jacobsen SEW, Mead AJ (2017)
    Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia
    Nat Med, 23 (6), 692-702
    DOI 10.1038/nm.4336, PubMed 28504724
  4. Inderberg EM, Mensali N, Oksvold MP, Fallang LE, Fåne A, Skorstad G, Stenvik GE, Progida C, Bakke O, Kvalheim G, Myklebust JH, Wälchli S (2017)
    Human c-SRC kinase (CSK) overexpression makes T cells dummy
    Cancer Immunol Immunother, 67 (4), 525-536
    DOI 10.1007/s00262-017-2105-9, PubMed 29248956
  5. Inderberg EM, Wälchli S, Myhre MR, Trachsel S, Almåsbak H, Kvalheim G, Gaudernack G (2017)
    T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth
    Oncoimmunology, 6 (4), e1302631
    DOI 10.1080/2162402X.2017.1302631, PubMed 28507809
  6. Josefsson SE, Huse K, Kolstad A, Beiske K, Pende D, Steen CB, Inderberg EM, Lingjærde OC, Østenstad B, Smeland EB, Levy R, Irish JM, Myklebust JH (2017)
    T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling
    Clin Cancer Res, 24 (4), 870-881
    DOI 10.1158/1078-0432.CCR-17-2337, PubMed 29217528
  7. Koksal H, Walchli S (2017)
    Fishing therapeutic T-cell receptors in healthy donor blood, is safety predictable?
    Transl. Cancer Res., 6 3, S622-S624
  8. Li X, Lu J, Kan Q, Li X, Fan Q, Li Y, Huang R, Slipicevic A, Dong HP, Eide L, Wang J, Zhang H, Berge V, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2017)
    Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
    Sci Rep, 7 (1), 5081
    DOI 10.1038/s41598-017-05086-6, PubMed 28698547
  9. Lilleby W, Gaudernack G, Brunsvig PF, Vlatkovic L, Schulz M, Mills K, Hole KH, Inderberg EM (2017)
    Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer
    Cancer Immunol Immunother, 66 (7), 891-901
    DOI 10.1007/s00262-017-1994-y, PubMed 28391357
  10. Morris JL, Fane A, Sarovich DS, Price EP, Rush CM, Govan BL, Parker E, Mayo M, Currie BJ, Ketheesan N (2017)
    Increased Neurotropic Threat from Burkholderia pseudomallei Strains with a B. mallei-like Variation in the bimA Motility Gene, Australia
    Emerg Infect Dis, 23 (5)
    DOI 10.3201/eid2305.151417, PubMed 28418830
  11. Nestvold J, Wang MY, Camilio KA, Zinöcker S, Tjelle TE, Lindberg A, Haug BE, Kvalheim G, Sveinbjørnsson B, Rekdal Ø (2017)
    Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model
    Oncoimmunology, 6 (8), e1338236
    DOI 10.1080/2162402X.2017.1338236, PubMed 28920000
  12. Schive SW, Mirlashari MR, Hasvold G, Wang M, Josefsen D, Gullestad HP, Korsgren O, Foss A, Kvalheim G, Scholz H (2017)
    Human Adipose-Derived Mesenchymal Stem Cells Respond to Short-Term Hypoxia by Secreting Factors Beneficial for Human Islets In Vitro and Potentiate Antidiabetic Effect In Vivo
    Cell Med, 9 (3), 103-116
    DOI 10.3727/215517917X693401, PubMed 28713640
  13. Walseng E, Köksal H, Sektioglu IM, Fåne A, Skorstad G, Kvalheim G, Gaudernack G, Inderberg EM, Wälchli S (2017)
    A TCR-based Chimeric Antigen Receptor
    Sci Rep, 7 (1), 10713
    DOI 10.1038/s41598-017-11126-y, PubMed 28878363

Publications 2016

  1. Belnoue E, Di Berardino-Besson W, Gaertner H, Carboni S, Dunand-Sauthier I, Cerini F, Suso-Inderberg EM, Wälchli S, König S, Salazar AM, Hartley O, Dietrich PY, Walker PR, Derouazi M (2016)
    Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants
    Mol Ther, 24 (9), 1675-85
    DOI 10.1038/mt.2016.134, PubMed 27377043
  2. Carretero R, Sektioglu IM, Garbi N, Salgado OC, Beckhove P, Hämmerling GJ (2016)
    Corrigendum: Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells
    Nat Immunol, 17 (2), 214
    DOI 10.1038/ni0216-214b, PubMed 26784268
  3. Eide HA, Halvorsen AR, Sandhu V, Fåne A, Berg J, Haakensen VD, Kure EH, Brustugun OT, Kiserud CE, Kyte JA, Helland Å (2016)
    Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease
    Clin Transl Immunology, 5 (11), e109
    DOI 10.1038/cti.2016.65, PubMed 27990285
  4. Elvsåshagen T, Zuzarte P, Westlye LT, Bøen E, Josefsen D, Boye B, Hol PK, Malt UF, Young LT, Andreazza AC (2016)
    Dentate gyrus-cornu ammonis (CA) 4 volume is decreased and associated with depressive episodes and lipid peroxidation in bipolar II disorder: Longitudinal and cross-sectional analyses
    Bipolar Disord, 18 (8), 657-668
    DOI 10.1111/bdi.12457, PubMed 27995733
  5. Kyte JA, Gaudernack G, Faane A, Lislerud K, Inderberg EM, Brunsvig P, Aamdal S, Kvalheim G, Wälchli S, Pule M (2016)
    T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy
    Oncoimmunology, 5 (12), e1249090
    DOI 10.1080/2162402X.2016.1249090, PubMed 28123886
  6. Kyte JA, Aamdal S, Dueland S, Sæbøe-Larsen S, Inderberg EM, Madsbu UE, Skovlund E, Gaudernack G, Kvalheim G (2016)
    Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
    Oncoimmunology, 5 (11), e1232237
    DOI 10.1080/2162402X.2016.1232237, PubMed 27999747
  7. Li X, Zhong Y, Lu J, Axcrona K, Eide L, Syljuåsen RG, Peng Q, Wang J, Zhang H, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2016)
    MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features
    Oncotarget, 7 (26), 40297-40313
    DOI 10.18632/oncotarget.9610, PubMed 27248169
  8. Mensali N, Ying F, Sheng VO, Yang W, Walseng E, Kumari S, Fallang LE, Kolstad A, Uckert W, Malmberg KJ, Wälchli S, Olweus J (2016)
    Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA
    Oncoimmunology, 5 (5), e1138199
    DOI 10.1080/2162402X.2016.1138199, PubMed 27467957
  9. Myklebust JH, Brody J, Kohrt HE, Kolstad A, Czerwinski DK, Wälchli S, Green MR, Trøen G, Liestøl K, Beiske K, Houot R, Delabie J, Alizadeh AA, Irish JM, Levy R (2016)
    Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling
    Blood, 129 (6), 759-770
    DOI 10.1182/blood-2016-05-718494, PubMed 28011673
  10. Schive SW, Foss A, Sahraoui A, Kloster-Jensen K, Hafsahl G, Kvalheim G, Lundgren T, von Zur-Mühlen B, Felldin M, Rafael E, Lempinen M, Korsgren O, Jenssen TG, Mishra V, Scholz H (2016)
    Cost and clinical outcome of islet transplantation in Norway 2010-2015
    Clin Transplant, 31 (1)
    DOI 10.1111/ctr.12871, PubMed 27862341
  11. Sioud M, Nyakas M, Sæbøe-Larssen S, Mobergslien A, Aamdal S, Kvalheim G (2016)
    Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
    Case Rep Med, 2016, 9639585
    DOI 10.1155/2016/9639585, PubMed 27504122

Publications 2015

  1. Almåsbak H, Walseng E, Kristian A, Myhre MR, Suso EM, Munthe LA, Andersen JT, Wang MY, Kvalheim G, Gaudernack G, Kyte JA (2015)
    Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model
    Gene Ther, 22 (5), 391-403
    DOI 10.1038/gt.2015.4, PubMed 25652098
  2. Naderi EH, Skah S, Ugland H, Myklebost O, Sandnes DL, Torgersen ML, Josefsen D, Ruud E, Naderi S, Blomhoff HK (2015)
    Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death
    Mol Cancer, 14, 14
    DOI 10.1186/s12943-014-0278-9, PubMed 25623255
  3. Tadesse FG, Mensali N, Fallang LE, Walseng E, Yang W, Olweus J, Wälchli S (2015)
    Unpredicted phenotypes of two mutants of the TcR DMF5
    J Immunol Methods, 425, 37-44
    DOI 10.1016/j.jim.2015.06.006, PubMed 26079729
  4. Yu D, Zhong Y, Li X, Li Y, Li X, Cao J, Fan H, Yuan Y, Ji Z, Qiao B, Wen JG, Zhang M, Kvalheim G, Nesland JM, Suo Z (2015)
    ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro
    Oncotarget, 6 (40), 42687-703
    DOI 10.18632/oncotarget.5883, PubMed 26528857

Publications 2014

  1. Husøy MA, Brinch L, Tjønnfjord GE, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I, Kolstad A, Akkök ÇA, Rollag H, Gaustad P, Bergan S, Egeland T, Josefsen D, Kvalheim G, Fløisand Y (2014)
    [Allogeneic stem-cell transplantation in adults 1985-2012: results and development]
    Tidsskr Nor Laegeforen, 134 (16), 1569-75
    DOI 10.4045/tidsskr.13.1415, PubMed 25178233
  2. Kolb HJ, Schmetzer H, Schmid C, Bigalke I, Buhmann R, Moosmann A, Falk C, Reuther S, Schuster F, Borkhardt A (2014)
    Mechanisms of graft-versus-leukemia effects after allogeneic stem cell transplantation: effects on the leukemia stem cell?
    Leuk Suppl, 3 (Suppl 1), S16-7
    DOI 10.1038/leusup.2014.9, PubMed 27175264
  3. Subklewe M, Geiger C, Lichtenegger FS, Javorovic M, Kvalheim G, Schendel DJ, Bigalke I (2014)
    New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia
    Cancer Immunol Immunother, 63 (10), 1093-103
    DOI 10.1007/s00262-014-1600-5, PubMed 25186611
  4. Woll PS, Kjällquist U, Chowdhury O, Doolittle H, Wedge DC, Thongjuea S, Erlandsson R, Ngara M, Anderson K, Deng Q, Mead AJ, Stenson L, Giustacchini A, Duarte S, Giannoulatou E, Taylor S, Karimi M, Scharenberg C, Mortera-Blanco T, Macaulay IC, Clark SA, Dybedal I, Josefsen D, Fenaux P, Hokland P et al. (2014)
    Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
    Cancer Cell, 25 (6), 794-808
    DOI 10.1016/j.ccr.2014.03.036, PubMed 24835589

Publications 2013

  1. Kaur K, Mirlashari MR, Kvalheim G, Kjeldsen-Kragh J (2013)
    3',4'-Dimethoxyflavone and valproic acid promotes the proliferation of human hematopoietic stem cells
    Stem Cell Res Ther, 4 (3), 60
    DOI 10.1186/scrt208, PubMed 23706670
  2. Rud AK, Borgen E, Mælandsmo GM, Flatmark K, Le H, Josefsen D, Solvoll I, Schirmer CB, Helland Å, Jørgensen L, Brustugun OT, Fodstad Ø, Boye K (2013)
    Clinical significance of disseminated tumour cells in non-small cell lung cancer
    Br J Cancer, 109 (5), 1264-70
    DOI 10.1038/bjc.2013.450, PubMed 23942067
  3. Vik-Mo EO, Nyakas M, Mikkelsen BV, Moe MC, Due-Tønnesen P, Suso EM, Sæbøe-Larssen S, Sandberg C, Brinchmann JE, Helseth E, Rasmussen AM, Lote K, Aamdal S, Gaudernack G, Kvalheim G, Langmoen IA (2013)
    Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
    Cancer Immunol Immunother, 62 (9), 1499-509
    DOI 10.1007/s00262-013-1453-3, PubMed 23817721
  4. Wang P, Gao Q, Suo Z, Munthe E, Solberg S, Ma L, Wang M, Westerdaal NA, Kvalheim G, Gaudernack G (2013)
    Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines
    PLoS One, 8 (3), e57020 (Retracted)
    DOI 10.1371/journal.pone.0057020, PubMed 23469181

Publications 2012

  1. Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE, Dybedal I, Holte H, Heldal D, Torfoss D, Aurlien E, Lauritzsen GF, Fosså A, Lehne G, Baggerød E, Kvalheim G, Egeland T, Bishop MR, Fowler DH, Kolstad A (2012)
    Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation
    Bone Marrow Transplant, 47 (12), 1552-7
    DOI 10.1038/bmt.2012.63, PubMed 22522568
  2. Johnson E, Førland DT, Hetland G, Sætre L, Olstad OK, Lyberg T (2012)
    Effect of AndoSan™ on expression of adhesion molecules and production of reactive oxygen species in human monocytes and granulocytes in vivo
    Scand J Gastroenterol, 47 (8-9), 984-92
    DOI 10.3109/00365521.2012.660544, PubMed 22564240
  3. Langmoen IA, Foss A, Kvalheim G, Engebretsen L, Glover JC (2012)
    [Stem cell research--new hope?]
    Tidsskr Nor Laegeforen, 132 (23-24), 2584
    DOI 10.4045/tidsskr.12.1324, PubMed 23338066
  4. Mathiesen RR, Borgen E, Renolen A, Løkkevik E, Nesland JM, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Kvalheim G, Lønning PE, Naume B (2012)
    Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival
    Breast Cancer Res, 14 (4), R117
    DOI 10.1186/bcr3242, PubMed 22889108

Publications 2011

  1. Eide MB, Lauritzsen GF, Kvalheim G, Kolstad A, Fagerli UM, Maisenhölder M, Østenstad B, Fluge Ø, Delabie J, Aarset H, Liestøl K, Holte H (2011)
    High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study
    Br J Haematol, 152 (5), 600-10
    DOI 10.1111/j.1365-2141.2010.08519.x, PubMed 21241276
  2. Førland DT, Johnson E, Saetre L, Lyberg T, Lygren I, Hetland G (2011)
    Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn's disease
    Scand J Immunol, 73 (1), 66-75
    DOI 10.1111/j.1365-3083.2010.02477.x, PubMed 21129005
  3. Hetland G, Johnson E, Lyberg T, Kvalheim G (2011)
    The Mushroom Agaricus blazei Murill Elicits Medicinal Effects on Tumor, Infection, Allergy, and Inflammation through Its Modulation of Innate Immunity and Amelioration of Th1/Th2 Imbalance and Inflammation
    Adv Pharmacol Sci, 2011, 157015
    DOI 10.1155/2011/157015, PubMed 21912538
  4. Josefsen D, Forfang L, Dyrhaug M, Blystad AK, Stokke T, Smeland EB, Kvalheim G (2011)
    Side population cells in highly enriched CD34-positive cells from peripheral blood progenitor cells identify an immature subtype of hematopoietic progenitor cells but do not predict time to engraftment in patients treated with high-dose therapy
    Eur J Haematol, 87 (6), 494-502
    DOI 10.1111/j.1600-0609.2011.01681.x, PubMed 21752097
  5. Mohty M, Duarte RF, Croockewit S, Hübel K, Kvalheim G, Russell N (2011)
    The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation
    Leukemia, 25 (1), 1-6
    DOI 10.1038/leu.2010.224, PubMed 21224858
  6. Suso EM, Dueland S, Rasmussen AM, Vetrhus T, Aamdal S, Kvalheim G, Gaudernack G (2011)
    hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
    Cancer Immunol Immunother, 60 (6), 809-18
    DOI 10.1007/s00262-011-0991-9, PubMed 21365467
  7. Torfoss D, Sandstad B, Mollnes TE, Høiby EA, Holte H, Bjerner J, Bjøro T, Gaudernack G, Kvalheim G, Kvaløy S (2011)
    The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily
    Scand J Immunol, 74 (6), 632-9
    DOI 10.1111/j.1365-3083.2011.02618.x, PubMed 21883353
  8. Zinöcker S, Wang MY, Gaustad P, Kvalheim G, Rolstad B, Vaage JT (2011)
    Mycoplasma contamination revisited: mesenchymal stromal cells harboring Mycoplasma hyorhinis potently inhibit lymphocyte proliferation in vitro
    PLoS One, 6 (1), e16005
    DOI 10.1371/journal.pone.0016005, PubMed 21264307

Publications 2010

  1. Almåsbak H, Rian E, Hoel HJ, Pulè M, Wälchli S, Kvalheim G, Gaudernack G, Rasmussen AM (2010)
    Transiently redirected T cells for adoptive transfer
    Cytotherapy, 13 (5), 629-40
    DOI 10.3109/14653249.2010.542461, PubMed 21174490
  2. Jantunen E, Kvalheim G (2010)
    Mobilization strategies in hard-to-mobilize patients with lymphoid malignancies
    Eur J Haematol, 85 (6), 463-71
    DOI 10.1111/j.1600-0609.2010.01520.x, PubMed 20738393
  3. Johnsen HE, Geisler C, Juvonen E, Remes K, Juliusson G, Hörnsten P, Kvaloy S, Kvalheim G, Jürgensen GW, Pedersen LM, Bergmann OJ, Schmitz A, Boegsted M (2010)
    Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment
    Bone Marrow Transplant, 46 (1), 44-51
    DOI 10.1038/bmt.2010.84, PubMed 20436517
  4. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Stromberg M, Wiedswang G, Kvalheim G, Karesen R, Nesland JM, Borresen-Dale AL, Sorlie T (2010)
    Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer (vol 1, pg 160, 2007)
    Mol. Oncol., 4 (2), 169
  5. Rasmussen AM, Borelli G, Hoel HJ, Lislerud K, Gaudernack G, Kvalheim G, Aarvak T (2010)
    Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy
    J Immunol Methods, 355 (1-2), 52-60
    DOI 10.1016/j.jim.2010.02.004, PubMed 20171968
  6. Tamburstuen MV, Reppe S, Spahr A, Sabetrasekh R, Kvalheim G, Slaby I, Syversen U, Lyngstadaas SP, Reseland JE (2010)
    Ameloblastin promotes bone growth by enhancing proliferation of progenitor cells and by stimulating immunoregulators
    Eur J Oral Sci, 118 (5), 451-9
    DOI 10.1111/j.1600-0722.2010.00760.x, PubMed 20831578
  7. Tamburstuen MV, Reseland JE, Spahr A, Brookes SJ, Kvalheim G, Slaby I, Snead ML, Lyngstadaas SP (2010)
    Ameloblastin expression and putative autoregulation in mesenchymal cells suggest a role in early bone formation and repair
    Bone, 48 (2), 406-13
    DOI 10.1016/j.bone.2010.09.007, PubMed 20854943

Publications 2009

  1. Huang TS, Grodeland G, Sleire L, Wang MY, Kvalheim G, Laerum OD (2009)
    Induction of circadian rhythm in cultured human mesenchymal stem cells by serum shock and cAMP analogs in vitro
    Chronobiol Int, 26 (2), 242-57
    DOI 10.1080/07420520902766025, PubMed 19212839

Publications 2008

  1. Ikdahl T, Josefsen D, Jakobsen E, Delabie J, Fosså SD (2008)
    Concurrent mediastinal germ-cell tumour and haematological malignancy: case report and short review of literature
    Acta Oncol, 47 (3), 466-9
    DOI 10.1080/02841860701636272, PubMed 18348004
  2. Lazarova P, Kvalheim G, Gercheva L, Metodiev K (2008)
    Experimental attempt to produce mRNA transfected dendritic cells derived from enriched CD34+blood progenitor cells
    Cent. Eur. J. Med., 3 (1), 21-28

Publications 2007

  1. Jarnjak-Jankovic S, Hammerstad H, Saebøe-Larssen S, Kvalheim G, Gaudernack G (2007)
    A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines
    BMC Cancer, 7, 119
    DOI 10.1186/1471-2407-7-119, PubMed 17608923
  2. Jarnjak-Jankovic S, Saebøe-Larssen S, Kvalheim G, Gaudernack G (2007)
    mRNA transfection of DC in the immature or mature state: comparable in vitro priming of Th and cytotoxic T lymphocytes against DC electroporated with tumor cell line-derived mRNA
    Cytotherapy, 9 (6), 587-92
    DOI 10.1080/14653240701466354, PubMed 17882723
  3. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Strømberg M, Wiedswang G, Kvalheim G, Kåresen R, Nesland JM, Børresen-Dale AL, Sørlie T (2007)
    Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
    Mol Oncol, 1 (2), 160-71
    DOI 10.1016/j.molonc.2007.03.004, PubMed 19383292

Publications 2006

  1. Drageset V, Nesland JM, Erikstein B, Skovlund E, Sommer H, Anker G, Wist E, Lundgren S, Bergh J, Kvalheim G (2006)
    Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy
    Int J Cancer, 118 (11), 2877-81
    DOI 10.1002/ijc.21709, PubMed 16381016
  2. Kyte JA, Kvalheim G, Lislerud K, thor Straten P, Dueland S, Aamdal S, Gaudernack G (2006)
    T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells
    Cancer Immunol Immunother, 56 (5), 659-75
    DOI 10.1007/s00262-006-0222-y, PubMed 16947019
  3. Lazarova P, Wu Q, Kvalheim G, Suo Z, Haakenstad KW, Metodiev K, Nesland JM (2006)
    Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood
    Int J Immunopathol Pharmacol, 19 (1), 49-56
    PubMed 16569339

Publications 2005

  1. Josefsen D, Fosså S (2005)
    The management strategies for stage I seminoma
    Clin Oncol (R Coll Radiol), 17 (7), 539-42
    DOI 10.1016/j.clon.2005.07.002, PubMed 16238141
  2. Kvalheim G (2005)
    Stem cell therapy still not here
    Cytotherapy, 7 (5), 456-7
    DOI 10.1080/14653240500319267, PubMed 16236635
  3. Kyte JA, Kvalheim G, Aamdal S, Saebøe-Larssen S, Gaudernack G (2005)
    Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination
    Cancer Gene Ther, 12 (6), 579-91
    DOI 10.1038/sj.cgt.7700837, PubMed 15818380
  4. Mu LJ, Kyte JA, Kvalheim G, Aamdal S, Dueland S, Hauser M, Hammerstad H, Waehre H, Raabe N, Gaudernack G (2005)
    Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
    Br J Cancer, 93 (7), 749-56
    DOI 10.1038/sj.bjc.6602761, PubMed 16136047

Publications 2004

  1. Abrahamsen JF, Rusten L, Bakken AM, Bruserud Ø (2004)
    Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide
    Transfusion, 44 (5), 785-9
    DOI 10.1111/j.1537-2995.2004.03336.x, PubMed 15104663
  2. Lazarova P, Lijun M, Hammerstad H, Nesland J, Gaudernack G, Kvalheim G (2004)
    Experimental attempt to introduce a vaccine therapy by using DC-developed from CD34+cells
    NATO SCI SER I LIFE, 361, 134
  3. Mu LJ, Lazarova P, Gaudernack G, Saeboe-Larssen S, Kvalheim G (2004)
    Development of a clinical grade procedure for generation of mRNA transfected dendritic cells from purified frozen CD34(+) blood progenitor cells
    Int J Immunopathol Pharmacol, 17 (3), 255-63
    DOI 10.1177/039463200401700305, PubMed 15461859
  4. Østby I, Kvalheim G, Rusten LS, Grøttum P (2004)
    Mathematical modeling of granulocyte reconstitution after high-dose chemotherapy with stem cell support: effect of post-transplant G-CSF treatment
    J Theor Biol, 231 (1), 69-83
    DOI 10.1016/j.jtbi.2004.05.010, PubMed 15363930

Publications 2003

  1. Kvalheim G, Gratwohl A, Urbano-Ispizua A, JACIE national representatives (2003)
    JACIE accreditation in Europe moves ahead
    Cytotherapy, 5 (4), 306-8
    DOI 10.1080/14653240310002216, PubMed 12944236
  2. Mu LJ, Gaudernack G, Saebøe-Larssen S, Hammerstad H, Tierens A, Kvalheim G (2003)
    A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines
    Scand J Immunol, 58 (5), 578-86
    DOI 10.1046/j.1365-3083.2003.01333.x, PubMed 14629630
  3. Ogreid P, Kvalheim G (2003)
    Old and new research into micrometastases in prostate cancer
    Scand. J. Urol. Nephrol., 37 212, 37-39
  4. Østby I, Rusten LS, Kvalheim G, Grøttum P (2003)
    A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation
    J Math Biol, 47 (2), 101-36
    DOI 10.1007/s00285-003-0198-6, PubMed 12883857

Publications 2001

  1. Aurlien E, Holte H, Kvaloy S, Jakobsen E, Rusten LS, Kvalheim G (2001)
    Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients
    Eur. J. Haematol., 66 64, 14-20
  2. Kvalheim G, Urbano-Ispizua A, Gratwohl A (2001)
    Regulatory aspects and accreditation of the clinical use of hematopoietic progenitor cells in Europe
    J Biol Regul Homeost Agents, 15 (1), 79-80
    PubMed 11388748

Publications 2000

  1. Aurlien E, Larsen RH, Kvalheim G, Bruland OS (2000)
    Demonstration of highly specific toxicity of the alpha-emitting radioimmunoconjugate(211)At-rituximab against non-Hodgkin's lymphoma cells
    Br J Cancer, 83 (10), 1375-9
    DOI 10.1054/bjoc.2000.1453, PubMed 11044364

Publications 1999

  1. Borgen E, Naume B, Nesland JM, Kvalheim G, Beiske K, Fodstad O, Diel I, Solomayer EF, Theocharous P, Coombes RC, Smith BM, Wunder E, Marolleau JP, Garcia J, Pantel K (1999)
    Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
    Cytotherapy, 1 (5), 377-88
    DOI 10.1080/0032472031000141283, PubMed 20426539
  2. Kvalheim G, Berli M (1999)
    EBMT and ISHAGE-Europe create a foundation for inspection and accreditation in Europe
    Cytotherapy, 1 (5), 363-4
    DOI 10.1080/0032472031000141280, PubMed 20426536
  3. Kvalheim G, Naume B, Nesland JM (1999)
    Minimal residual disease in breast cancer
    Cancer Metastasis Rev, 18 (1), 101-8
    DOI 10.1023/a:1006216504892, PubMed 10505549

Publications 1998

  1. Aurlien E, Holte H, Pharo A, Kvaløy S, Jakobsen E, Smeland EB, Kvalheim G (1998)
    Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma
    Bone Marrow Transplant, 21 (9), 873-8
    DOI 10.1038/sj.bmt.1701192, PubMed 9613778
  2. Borgen E, Beiske K, Trachsel S, Nesland JM, Kvalheim G, Herstad TK, Schlichting E, Qvist H, Naume B (1998)
    Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase
    J Pathol, 185 (4), 427-34
    DOI 10.1002/(SICI)1096-9896(199808)185:4<427::AID-PATH127>3.0.CO;2-7, PubMed 9828843
  3. Kvalheim G (1998)
    Detection and quantification of residual disease in bone marrow and PBPC
    EUROCANCER 98, 19-21
  4. Kvalheim G (1998)
    Diagnosis of minimal residual disease in bone marrow and blood in cancer patients--methods and clinical implications
    Acta Oncol, 37 (5), 455-62
    DOI 10.1080/028418698430403, PubMed 9831374
  5. Naume B, Borgen E, Nesland JM, Beiske K, Gilen E, Renolen A, Ravnås G, Qvist H, Kåresen R, Kvalheim G (1998)
    Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation
    Int J Cancer, 78 (5), 556-60
    DOI 10.1002/(sici)1097-0215(19981123)78:5<556::aid-ijc5>3.0.co;2-g, PubMed 9808522

Publications 1996

  1. Kvalheim G (1996)
    Purging of autografts: methods and clinical significance
    Ann Med, 28 (2), 167-73
    DOI 10.3109/07853899609092942, PubMed 8732646
  2. Kvalheim G (1996)
    Detection of occult tumour cells in bone marrow and blood in breast cancer patients--methods and clinical significance
    Acta Oncol, 35 Suppl 8, 13-8
    DOI 10.3109/02841869609098516, PubMed 9073044
  3. Kvalheim G, Holte H, Jakobsen E, Kvaloy S (1996)
    Immunomagnetic purging of lymphoma cells from autografts
    J Hematother, 5 (5), 561-2
    DOI 10.1089/scd.1.1996.5.561, PubMed 8938530
  4. Kvalheim G, Wang MY, Pharo A, Holte H, Jacobsen E, Beiske K, Kvaløy S, Smeland E, Funderud S, Fodstad O (1996)
    Purging of tumor cells from leukapheresis products: experimental and clinical aspects
    J Hematother, 5 (4), 427-36
    DOI 10.1089/scd.1.1996.5.427, PubMed 8877718

Publications 1995

  1. Josefsen D, Waehre H, Paus E, Fosså SD (1995)
    Increase of serum prostatic specific antigen and clinical progression in pN + MO prostate cancer
    Br J Urol, 75 (4), 502-6
    DOI 10.1111/j.1464-410x.1995.tb07273.x, PubMed 7540482

Publications 1994

  1. Kvalheim G, Jakobsen E, Holte H, Beiske K, Langholm R, Høiby A, Wang MY, Funderund S, Fodstad O, Smeland E (1994)
    Autologous bone marrow transplantation of non-Hodgkin's lymphoma patients with marrow purged using immunomagnetic beads
    Prog Clin Biol Res, 389, 133-8
    PubMed 7700895
  2. SCHNEEDE J, MORTENSEN JH, KVALHEIM G, UELAND PM (1994)
    CAPILLARY ZONE ELECTROPHORESIS WITH LASER-INDUCED FLUORESCENCE DETECTION FOR ANALYSIS OF METHYLMALONIC ACID AND OTHER SHORT-CHAIN DICARBOXYLIC-ACIDS DERIVATIZED WITH 1-PYRENYLDIAZOMETHANE
    J. Chromatogr. A, 669 (1-2), 185-193

Publications 1993

  1. Josefsen D, Ous S, Høie J, Stenwig AE, Fosså SD (1993)
    Salvage treatment in male patients with germ cell tumours
    Br J Cancer, 67 (3), 568-72
    DOI 10.1038/bjc.1993.104, PubMed 8382512

Publications 1992

  1. SMELAND EB, FUNDERUD S, KVALHEIM G, EGELAND T (1992)
    EFFECTIVE ISOLATION OF HUMAN HEMATOPOIETIC PROGENITOR CELLS - A NEW METHOD FOR DETACHMENT OF IMMUNOMAGNETIC BEADS FROM POSITIVELY SELECTED CD34+ CELLS
    INT J CELL CLONING, 10 1, 108-110
  2. Straka C, Kröner C, Dörken B, Kvalheim G (1992)
    Polymerase chain reaction monitoring shows a high efficacy of clinical immunomagnetic purging in patients with centroblastic-centrocytic non-Hodgkin's lymphoma
    Blood, 80 (10), 2688-90
    PubMed 1421385

Publications 1988

  1. KVALHEIM G, FODSTAD O, FUNDERUD S, KIESEL S, DORKEN B, NUSTAD K, PIHL A (1988)
    IMMUNOMAGNETIC PURGING OF BETA-LYMPHOMA CELLS FROM BONE-MARROW
    Bone Marrow Transplant., 3 1, 97
  2. UGELSTAD J, BERGE A, ELLINGSEN T, AUNE O, KILAAS L, NILSEN TN, SCHMID R, STENSTAD P, FUNDERUD S, KVALHEIM G, NUSTAD K, LEA T, VARTDAL F, DANIELSEN H (1988)
    MONOSIZED MAGNETIC PARTICLES AND THEIR USE IN SELECTIVE CELL-SEPARATION
    MAKROMOL CHEM-M SYMP, 17, 177-211

Publications 1987

  1. GRAHAMPOLE J, BAST R, KERSEY J, JANOSSY G, NADLER L, MARTIN P, KERNAN N, HAMILTON B, PHILIP T, KVALHEIM G, KEMSHEAD J, GEE A (1987)
    ANTIBODY-MEDIATED METHODS - ALLOGRAFTS AND AUTOGRAFTS - DISCUSSION
    Bone Marrow Transplant., 2 2, 99-103
  2. Kvalheim G, Fodstad O, Pihl A, Nustad K, Pharo A, Ugelstad J, Funderud S (1987)
    Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies
    Cancer Res, 47 (3), 846-51
    PubMed 3492268
  3. NUSTAD K, MICHAELSEN TE, KIERULF B, FJELD JG, KVALHEIM G, PIHL A, UGELSTAD J, FUNDERUD S (1987)
    ANTIGEN-BINDING PROPERTIES OF ANTIBODIES COATED ON MAGNETIC POLYMER BEADS
    Bone Marrow Transplant., 2 2, 81-83
  4. VARTDAL F, ALBRECHTSEN D, RINGDEN O, KVALHEIM G, LEA T, BOSNES V, GAUDERNACK G, BRINCHMANN J, UGELSTAD J (1987)
    IMMUNOMAGNETIC TREATMENT OF BONE-MARROW ALLOGRAFTS
    Bone Marrow Transplant., 2 2, 94-98
  5. Vartdal F, Kvalheim G, Lea TE, Bosnes V, Gaudernack G, Ugelstad J, Albrechtsen D (1987)
    Depletion of T lymphocytes from human bone marrow. Use of magnetic monosized polymer microspheres coated with T-lymphocyte-specific monoclonal antibodies
    Transplantation, 43 (3), 366-71
    DOI 10.1097/00007890-198703000-00010, PubMed 3103274

Publications 1986

  1. Mustafa AS, Kvalheim G, Degre M, Godal T (1986)
    Mycobacterium bovis BCG-induced human T-cell clones from BCG-vaccinated healthy subjects: antigen specificity and lymphokine production
    Infect Immun, 53 (3), 491-7
    DOI 10.1128/IAI.53.3.491-497.1986, PubMed 2427449

Publications 1985

  1. Kvalheim G, Gundersen S, Hager B, Fodstad O (1985)
    Intra-arterial infusion of mitomycin C in treatment of breast cancer: occurrence of skin necrosis in irradiated patients
    Radiother Oncol, 4 (2), 127-32
    DOI 10.1016/s0167-8140(85)80099-2, PubMed 3934716
  2. Ueland PM, Kvalheim G, Lønning PE, Kvinnsland S (1985)
    Determination of warfarin in human plasma by high performance liquid chromatography and photodiode array detector
    Ther Drug Monit, 7 (3), 329-35
    DOI 10.1097/00007691-198507030-00018, PubMed 4049474

Publications 1984

  1. Fodstad O, Kvalheim G, Godal A, Lotsberg J, Aamdal S, Høst H, Pihl A (1984)
    Phase I study of the plant protein ricin
    Cancer Res, 44 (2), 862-5
    PubMed 6692385
 
Page visits: 6568